07 June 2005

 

MedReview Selects Tumbleweed to Protect Highly Sensitive Emails; MailGate Email Firewall and Secure Messenger Provide Outbound Email Encryption and Bl

Tumbleweed(R) Communications Corp. (Nasdaq:TMWD), a leading provider of email and file transfer security solutions, announced today that MedReview Inc., a leader in medical reviews and programs for prospective, concurrent and retrospective monitoring, has implemented the Tumbleweed MailGate Email Firewall(TM) and Secure Messenger(TM) products to protect critical information, meet regulatory compliance requirements, and significantly reduce IT costs.
MedReview, a subsidiary of the New York County Health Services Review Organization (NYCHSRO) which was established in 1974 as one of the first physicians' peer review organizations in the United States, provides its clients with guaranteed cost-effective case management and utilization analysis approaches that can assist them in developing or negotiating more cost-efficient benefit plan strategies. As businesses like MedReview aggressively expand the use of email to help streamline communications and cut costs, the privacy and security of personal and confidential information shared via email is a top concern. This concern, combined with regulations like the Health Insurance Portability and Accountability Act (HIPPA) and Sarbanes-Oxley, imposes email security and management requirements which most email systems don't meet.
To address regulatory issues and ensure client privacy, MedReview implemented the Tumbleweed's MailGate Email Firewall and Secure Messenger solutions to protect, filter and secure email traffic throughout the organization's communications network. MailGate Email Firewall supports and protects more than 300 email users and scans over 1 million messages a month, blocking spam and viruses before they reach the email server.
"HIPAA was a real challenge, but with Tumbleweed there was no need for additional training. Tumbleweed integrates seamlessly with Microsoft Outlook, so people just sent their emails," said Vlad Safyanovskiy, senior technology officer of MedReview.
MailGate Secure Messenger also meets high security requirements by encrypting the more than 2,500 outgoing messages per month to address PHI-related concerns. MedReview now relies on Tumbleweed to inspect every incoming and outgoing email communication to detect and disinfect potentially damaging messages. As an added benefit, the Tumbleweed solutions also protect MedReview against worms, Trojan horses and other malicious threats in all major file types, including mobile code and compressed file formats.
"We understand that the benefits of fully utilizing email within the healthcare industry carry significant risks if the traffic is not properly secured and managed. We've optimized our MailGate solutions for highly confidential, mission-critical applications to ensure that our customers meet both regulatory requirements and their user's expectations," said Joe Fisher, VP of Marketing, Tumbleweed Communications. "As a leader in the healthcare industry, MedReview turned to the leader in email security to provide them with the most reliable, customizable and cost-effective email solution to address not only security but also compliance related issues."
About Tumbleweed MailGate Email Firewall
Tumbleweed MailGate Email Firewall has been recognized as having the best email security product functionality by META Group, and was rated the #1 enterprise software solution for fighting spam, according to Network World (http://www.nwfusion.com/reviews/2003/0915spam.html). Tumbleweed MailGate Email Firewall protects, filters and secures email traffic at the Internet gateway with an integrated set of anti-spam, anti-virus, anti-hacker, content filtering, email relay and encrypted messaging capabilities -- minimizing email communications risks and reducing email management costs. Tumbleweed MailGate Email Firewall is used by more than 650 of the world's largest, most demanding messaging infrastructures, and is available in both appliance and software editions.
About Tumbleweed's Secure Messenger
MailGate Secure Messenger(TM), now in its sixth generation, is the leading software solution for securing email communications. Currently deployed at some of the most demanding enterprises in the Global 2000, MailGate Secure Messenger enables organizations to meet their own unique security needs -- from compliance with government privacy regulations in Healthcare (HIPAA) and Financial Services (GLBA) to enforcement of corporate policies (SOX) and protection of intellectual property.
Secure Messenger works with the MailGate Email Firewall to inspect all outbound email at the network gateway. Based on policies that your organization defines, it automatically identifies violations based on the content of the email, and redirects suspect messages to a secure, encrypted channel for further action. This perimeter-based design ensures that all users comply with enterprise privacy and security policies all the time -- without the need to install software on every desktop.
About MedReview Inc.
MedReview is a subsidiary of New York County Health Services Review Organization (NYCHSRO), which was established in 1974 in New York State as one of the first physicians' peer review organizations in the United States. The company's goals were then, and continue to be, improvements in the quality, appropriateness, and cost-effectiveness of health care services.
About Tumbleweed Communications Corp.
Tumbleweed provides security solutions for email protection, file transfers, and identity validation that allow organizations to safely conduct business over the Internet. Tumbleweed offers these solutions in three comprehensive product suites: MailGate, SecureTransport, and Validation Authority. MailGate provides protection against spam, viruses, and attacks, and enables policy-based message filtering, encryption, and routing. SecureTransport enables business to safely exchange large files and transactions without proprietary software. The Validation Authority is the world-leading solution for determining the validity of digital certificates. Tumbleweed's enterprise and government customers include ABN Amro, Bank of America Securities, Catholic Healthcare West, JP Morgan Chase & Co., The Regence Group (Blue Cross/Blue Shield), St. Luke's Episcopal Healthcare System, the US Food and Drug Administration, the US Department of Defense, and all four branches of the US Armed Forces. Tumbleweed was founded in 1993 and is headquartered in Redwood City, Calif. For additional information about Tumbleweed go to www.tumbleweed.com or call 650-216-2000.
Safe Harbor Statement
Tumbleweed cautions that forward-looking statements contained in this press release are based on plans and expectations as of the date of the press release, and that a number of factors could cause the actual results to differ materially from the guidance given at this time. These factors are described in the Safe Harbor statement below.
Except for the historical information contained herein, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected, particularly with respect to Tumbleweed products and Tumbleweed's Healthcare business. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. For further cautions about the risks of investing in Tumbleweed, we refer you to the documents Tumbleweed files from time to time with the Securities and Exchange Commission, particularly Tumbleweed's Form 10-K filed March 16, 2005 and Form 10-Q filed May 10, 2005.
Tumbleweed assumes no obligation to update information contained in this press release, which represents the Company's expectations only as of the date of this release and should not be viewed as a statement about the Company's expectations after such date. Although this release may remain available on the Company's website or elsewhere, its continued availability does not indicate that the Company is reaffirming or confirming any of the information contained herein.

Comments: Post a Comment

<< Home

This page is powered by Blogger. Isn't yours?